Psychiatry

The mortality rate has not declined since the 1970s.

Investigators push for a greater understanding of the disease in relation to the mental health of young patients, which has affected roughly 20% of the global pediatric population.

There are several clinical trials testing psychedelics as a treatment option for psychiatric disorders.

Sexual dysfunction in men was related to clinical factors, including erectile dysfunction, while women reported low emotional well-being and symptoms of anxiety.

Six-month paliperidone palmitate is the only twice-yearly injectable treatment for patients with schizophrenia.

A lack of PPE and high patient volumes were the leading causes of distress for nurses.

Depression is the leading cause of disability in the US.

There are a number of ongoing clinical trials testing psychedelics as a treatment for psychiatric disorders.

Patients with severe mental health issues often are linked to health inequalities that contribute to a shorter life expectancy than the general population.

Developed by BrainsWay, the new device has been shown to decrease anxiety symptoms in adult patients with anxious depression.

There was little difference in hospitalization and mortality rates between vaccinated schizophrenia patients and vaccinated control patients.

There has been a lot of variance in mental health studies during the COVID-19 pandemic.

Schizophrenia PRS was linked to increased disorganized symptom dimension scores.

More than half of DAA prescriptions were prescribed by specialists like gastroenterologist and infectious disease physicians.

The COVID-19 pandemic may have exposed more disparities based on race or ethnicity in ADHD care.

Higher depressive and manic (symptoms were associated with lower GAF, most strongly among the older participants.

Severe mental disorders had the highest odds ratios for the risk of mortality.

OnabotulinumtoxinA treatment may now include 8 new muscles.

For only reward learning, anhedonia was associated with model-derived learning parameters and neural learning signals.

CBGT and MBSR were both associated with a significant decrease in negative emotion.

On this episode of Coping After COVID, Dr. Craig Chepke discusses the challenges for schizophrenia patients.

Data show total amount of patients pre-guideline was 558,175 compared to 532,962 patients after the release of the guideline.

Researchers found the strongest associations between ADHD and nervous system disorders and respiratory diseases.

There was no evidence found suggesting children with lower emotion regulation ability at years old had greater probability of later reporting symptoms of broad anorexia nervosa.

Methylphenidate hydrochloride (Adhansia XR) was originally approved in 2019 for ADHD patients at least 6 years old.